The association between naltrexone treatment and symptoms of depression in opioid-dependent patients

REFERENCES

• Wang D, Sun X, Sadee W. Different effects of opiate antagonists on mu-, delta-, and kappa-opiate receptors with and without agonist pretreatment. The J Pharmacol Exp Ther 2007; 321: 544–552.
   PubMed Web of Science ®Google Scholar
• Sullivan MA, Vosburg SK, Comer SD. Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology 2006; 189: 37–46.
   PubMed Web of Science ®Google Scholar
• O'Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann of Intern Med 2000; 133: 40–54.
   PubMed Web of Science ®Google Scholar
• Kirchmayer U, Davoli M, Verster AD, Amato L, Ferri M, Perucci CA. A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction. 2002; 97: 1241–1249.
   PubMed Web of Science ®Google Scholar
• Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Syst Rev 2006; (1): CD001333.
   PubMed Web of Science ®Google Scholar
• Sullivan MA, Rothenberg JL, Vosburg SK, Church SH, Feldman SJ, Epstein EM, Kleber HD, Nunes EV Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial. Am J Addict 2006; 15: 150–159.
   PubMed Web of Science ®Google Scholar
• Carpenter KM, Jiang H Sullivan MA, Bisaga A, Comer SD Raby WN, Brooks AC, Nunes EV Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence. Psychol Addict Behav 2009; 23: 47–55.
   PubMed Web of Science ®Google Scholar
• Miotto K, McCann M, Basch J, Rawson R, Ling W. Naltrexone and dysphoria: fact or myth? Am J Addict 2002; 11: 151–160.
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Ellingboe J, Keuhnle JC, Mello NK. Effects of naltrexone on mood and neuroendocrine function in normal adult males. Psychoneuroendocrinilogy 1979; 3: 231–236.
   Web of Science ®Google Scholar
• Hollister LE, Johnson K, Boukhabza D, Gillespie HK. Aversive effects of naltrexone in subjects not dependent on opiates. Drug and Alcohol Dependence. 1981; 8: 37–41.
   PubMed Web of Science ®Google Scholar
• Crowley TJ, Wagner JE, Zerbe G, Macdonald M. Naltrexone-induced dysphoria in former opioid addicts. Am J Psychiatry 1985; 142(9): 1081–1084.
   PubMed Web of Science ®Google Scholar
• Petrakis I, Ralevski E, Nich C, Levinson C, Carroll K, Poling J, Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and current depression. J Clin Psychopharmacology 2007; 27(2): 160–165.
   PubMed Web of Science ®Google Scholar
• Dean AJ, Saunders JB, Jones RT, Young RM, Connor JP, Lawford BR. Does naltrexone treatment lead to depression? J Psychiatry and Neuroscis. 2006; 31(11): 38–45.
   PubMed Web of Science ®Google Scholar
• Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV. Behavioral naltrexone therapy: an integrated treatment for opiate dependence. J Subst Abuse Treat 2002; 23(4):351–360.
   PubMed Web of Science ®Google Scholar
• Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology 2002; 159(4): 351–360.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description”. Arch Gen Psychiatry 1992; 49(8):624–629.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, November 2002.
   Google Scholar
• Hamilton M. A rating scale for depression J Neurol, Neurosurg Psychiatry 1960; 23: 56–62.
   PubMed Web of Science ®Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6: 278–296.
   PubMed Web of Science ®Google Scholar
• Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol. 2006; 62(1): 123–146.
   PubMed Web of Science ®Google Scholar
• Brady KT, Myrick H, Sonne S. Co-occurring addictive and affective disorders. In Principles of Addiction Medicine. (3rd ed.). Graham AW, Schultz TK, Mayo-Smith MF, Ries RR, Wilford BB, eds. Chevy Chase, MD: American Society of Addiction Medicine, 2003; 1277–1286.
   Google Scholar
• Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Depend 2005; 78: 309–315.
   PubMed Web of Science ®Google Scholar
• Mintz J, O'brien CP, Woody G, Beck AT. Depression in treated narcotic addicts, ex-addicts, nonaddicts, and suicide attempters. Am J Drug and Alcohol Abuse 1979; 6(4):385–396.
   PubMed Web of Science ®Google Scholar
• Steer RA, Emery GD, Beck AT. Correlates of self-reported and clinically assessed depression in male heroin addicts. J Clin Psychology 1980; 56(3): 798–800.
   Google Scholar
• Woody GE, O'Brien CP, Rickels K. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. American Journal of Psychiatry, 1975; 132: 447–450.
   PubMed Web of Science ®Google Scholar
• Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, Woody G. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial. Arch Gen Psychiatry 1998; 55: 153–160.
   PubMed Web of Science ®Google Scholar
• Stein MD, Solomon DA, Herman DS, Anthony JL, Ramsey SE, Anderson BJ, Miller IW. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatry 2004; 61(2): 152–159.
   PubMed Web of Science ®Google Scholar